SHH · Financial Statements

Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) Financial Statements

$6.57 SHH: 600222.SS Market Cap $4.41B

Full income statement, balance sheet, and cash flow statement for Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio1.20
EV / EBITDA31.11
FCF Yield—
Quick Ratio0.92
Interest Coverage—
Return 1Y1.76%
Return 3Y8.94%
Return 5Y-18.59%

Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) financials — frequently asked questions

What is 600222.SS EV/EBITDA?

Henan Taloph Pharmaceutical Stock Co.,Ltd's enterprise value to EBITDA (EV/EBITDA) ratio is 31.11.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
600222.SS Overview 600222.SS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.